Novel therapeutic directions for Parkinson's disease

scientific article published on July 1995

Novel therapeutic directions for Parkinson's disease is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S1357-4310(95)91888-4
P698PubMed publication ID9415155

P2093author name stringGage FH
Fisher LJ
P2860cites workDirect intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's diseaseQ64383353
Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in cultureQ69495898
In vitro neuronal production and differentiation by precursor cells derived from the adult human forebrainQ72126631
Nerve growth factor released by transgenic astrocytes enhances the function of adrenal chromaffin cell grafts in a rat model of Parkinson's diseaseQ72452133
Enhanced survival and neuronal differentiation of adrenal chromaffin cells cografted into the striatum with NGF-producing fibroblastsQ72575525
Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons--II. Effects on nigral transplants in vivoQ72624582
Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNFQ24310580
GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neuronsQ24336322
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivoQ28306009
Intracerebral adrenal medulla grafts: a reviewQ28334372
Isolation, Characterization, and use of Stem Cells from the CNSQ34299470
The neostriatal mosaic: multiple levels of compartmental organizationQ35318347
Visualization of migration of transplanted astrocytes using polystyrene microspheresQ36453463
Neural transplantation for Parkinson's disease: a critical appraisal.Q37522844
Adrenal Chromaffin Cells Transdifferentiate in Response to Basic Fibroblast Growth Factor and Show Directed Outgrowth to a Nerve Growth Factor Source in VivoQ38937460
A radical hypothesis for neurodegenerationQ40385988
Dopaminergic neural grafts after fifteen years: results and perspectives.Q40576807
Grafting in the mammalian central nervous systemQ40825814
In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neuronsQ41379191
Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brainQ41379201
The use of genetically altered astrocytes to provide nerve growth factor to adrenal chromaffin cells grafted into the striatumQ41661372
Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's diseaseQ41671744
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brainQ42280576
Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylaseQ43185222
Transplantation to the rat brain of human neural progenitors that were genetically modified using adenovirusesQ44515156
Neural-targeted gene therapy for rodent and primate hemiparkinsonismQ45866224
Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease.Q45942003
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's diseaseQ48184014
Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons--I. Effects in vitro.Q48229447
Environmental influences in the development of neural crest derivatives: glucocorticoids, growth factors, and chromaffin cell plasticity.Q52266132
P433issue4
P1104number of pages7
P304page(s)181-187
P577publication date1995-07-01
P1433published inTrends in Molecular MedicineQ15265842
P1476titleNovel therapeutic directions for Parkinson's disease
P478volume1

Reverse relations

cites work (P2860)
Q34031071Approach to ex vivo gene therapy in the treatment of Parkinson's disease
Q34003138Cellular transplants as sources for therapeutic agents
Q48825544Neuronal stem cells express vesicular monoamine transporter 2 immunoreactivity in the adult rat.
Q30476054Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain
Q31895751Self-oligomerization and protein aggregation of alpha-synuclein in the presence of Coomassie Brilliant Blue

Search more.